Delcath Systems Overview
- Year Founded
-
1988
- Status
-
Public
- Employees
-
76
- Stock Symbol
-
DCTH
- Share Price
-
$11.87
- (As of Tuesday Closing)
Delcath Systems General Information
Description
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Contact Information
Website
www.delcath.comCorporate Office
- 566 Queensbury Avenue
- Queensbury, NY 12804
- United States
Corporate Office
- 566 Queensbury Avenue
- Queensbury, NY 12804
- United States
Delcath Systems Timeline
Delcath Systems Stock Performance
As of 22-Apr-2025, Delcath Systems’s stock price is $11.87. Its current market cap is $397M with 33.4M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $11.87 | $11.34 | $5.04 - $16.97 | $397M | 33.4M | 436K | -$0.93 |
Delcath Systems Financials Summary
As of 31-Dec-2024, Delcath Systems has a trailing 12-month revenue of $37.2M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 386,626 | 386,626 | 61,241 | 42,741 |
| Revenue | 37,205 | 37,205 | 2,065 | 2,719 |
| EBITDA | (26,282) | (26,282) | (45,840) | (33,691) |
| Net Income | (26,386) | (26,386) | (47,678) | (36,508) |
| Total Assets | 76,589 | 76,589 | 38,613 | 17,862 |
| Total Debt | 1,038 | 1,038 | 10,187 | 15,874 |
Delcath Systems Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Delcath Systems Comparisons
Industry
Financing
Details
Delcath Systems Competitors (1)
One of Delcath Systems’s competitors is Sirtex Medical, a Private Equity-Backed company based in Woburn, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sirtex Medical | Private Equity-Backed | Woburn, MA |
Delcath Systems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Delcath Systems Patents
Delcath Systems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200300839-A1 | Method of selecting chemotherapeutic agents for an isolated organ or regional therapy | Active | 28-Aug-2012 | ||
| US-11867686-B2 | Method of selecting chemotherapeutic agents for an isolated organ or regional therapy | Active | 28-Aug-2012 | ||
| US-20240102993-A1 | Method of selecting chemotherapeutic agents for an isolated organ or regional therapy | Pending | 28-Aug-2012 | ||
| AU-343454-S | Dual filter | Inactive | 29-Dec-2011 | ||
| US-20130168332-A1 | Adjustable filter apparatus | Inactive | 29-Dec-2011 | A61M1/3643 |
Delcath Systems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Delcath Systems Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Delcath Systems FAQs
-
When was Delcath Systems founded?
Delcath Systems was founded in 1988.
-
Where is Delcath Systems headquartered?
Delcath Systems is headquartered in Queensbury, NY.
-
What is the size of Delcath Systems?
Delcath Systems has 76 total employees.
-
What industry is Delcath Systems in?
Delcath Systems’s primary industry is Diagnostic Equipment.
-
Is Delcath Systems a private or public company?
Delcath Systems is a Public company.
-
What is Delcath Systems’s stock symbol?
The ticker symbol for Delcath Systems is DCTH.
-
What is the current stock price of Delcath Systems?
As of 22-Apr-2025 the stock price of Delcath Systems is $11.87.
-
What is the current market cap of Delcath Systems?
The current market capitalization of Delcath Systems is $397M.
-
What is Delcath Systems’s current revenue?
The trailing twelve month revenue for Delcath Systems is $37.2M.
-
Who are Delcath Systems’s competitors?
Sirtex Medical is a competitor of Delcath Systems.
-
What is Delcath Systems’s annual earnings per share (EPS)?
Delcath Systems’s EPS for 12 months was -$0.93.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
